Daisy Zhou join Reistone and served as Head of Preclinical and Translational Science since Nov.2019. Daisy worked over 12 years in drug discovery in Pharmaceutical R&D, she has accumulated significant experience in autoimmune immune diseases and immune-oncology drug discovery and translational science.
Prior to joining Reistone Biopharma, Daisy served for GlaxoSmithKline, Zailab and Novartis and worked as project leader for several Biologics as well as small molecule projects.
Daisy obtained B.S. diploma in Medicine in Shanghai JiaoTong University, then Ph.D degree of Immunology in University of Brussels and Postdoc training in Institute for Medical Immunology.